RSS Feeds
Search

Press releases

Stay current with the latest press releases from within the industry.

Submit Press Release

A Pharmalicensing Intelligence subscription will allow you to submit press release drafts. Press release drafts are assessed and published by our Pharmalicensing Intelligence team.

Latest Press Releases

Beacon Launch New Website

Beacon announces the launch of a new improved website to enhance communications with our stakeholders. more

Beacon Launch Streptokinase

Beacon Pharmaceuticals Ltd is pleased to announce the launch in the UK of Stretokinase. more

A New Therapeutic Approach to Treat Oral Mucositis Using Specific MMP Blockers in an Osmotically Active Solution.

Abstract
Mucositis is a consequence of cytostatic effects of anticancer therapy on the fast growing oral mucosal cells. The size of the ulcer increases due to subsequent bacterial and fungal... more

VITRO-BIO Pharma

General Information
VITRO-BIO Pharma France
ZAC de Lavaur
63500 ISSOIRE
France
www.vitrobio.com

Founded 1994
Private ownership more

Press release search

Search the Pharmalicensing Press Releases by keyword. Alternatively our advanced search allows you to query by therapeutic target and industry sector.
Year Industrial sector
Therapeutic target
 
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent press releases

Comparison of a Hypertonic Tannin-rich Solution vs 3% NaCl Solution as Treatment for Rhinosinusitis

ABSTRACT
Rhinosinusitis (RS), chiefly viral in origin, is increasingly widespread, and puts heavy financial burdens on society. Treatments range from home remedies and alpha-adrenergic agonistic decongestants to antibiotics, corticosteroids, and even (more)

Innopharmax announces its participation in BIO International Convention 2013 in Chicago(4/22-25). Booth number: 4878

Innopharmax announces its participation in BIO International Convention 2013 in Chicago(4/22-25). Booth number: 4878 (more)

One of the Most International and Economic Partnering Conferences

EUR 35 and 55 per pre-arranged face-to-face meeting makes euroPLX unmatched in terms of economy. (more)

ASSOCIATING A HYPERTONIC SOLUTION WITH SPECIFIC PLANT PROCYANIDINS FOR THE TREATMENT OF GENITAL HERPES

ABSTRACT

Presence of free Herpes Simplex Virus (HSV) particles in the vaginal cavity and consequent continuous infection of new healthy cells delay the recovery from Genital herpes (GHSV). As the HSV envelop contains several surface proteins an (more)

euroPLX Meetings to Continue Strongly in 2013

euroPLX announces confirmed events in 2013, all open for registration. (more)

Jubilee euroPLX Meeting Attracted Opportunities From 36 Countries

The 50th "jubilee" euroPLX Meeting in Sorrento marks an important milestone; world's most often held pharma partnering event. (more)

Rivastigmine Patch for LATAM Markets

Amarin Technologies S.A. has licensed its Rivastigmine Patch to Asofarma S.A. , for Brazil and Argentina markets. (more)

euroPLX 50 Sorrento - More Global Opportunities Than Ever

euroPLX partnering conferences more international than other pharma or biotech partnering events and are becoming ever more global as the 50th euroPLX Meeting shows. (more)

Labtec joins the CPHI/ICSE in Madrid, October 9-11th, 2012

The International Contract Service Event (“ICSE”), taking place in Madrid from 9th until 11th October 2012, is co-located with the “CPhI Worldwide” – the biggest international fair for the pharmaceutical industry. (more)

TESTAGEN™ TDS FUNDED FOR TESTING

Unique Low T treatment expected to eliminate the problematic transference side effect (more)

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us